Webinar Event
October 13, 2020, 4:30pm EDT
Register here.
This year’s US ECM Roundtable will be held as a virtual two-part series, which will bring together senior market professionals to assess current themes in the industry and provide an outlook for the future.
The second session, SPACs Boom onto the Market in 2020 as
Webinar Event
October 6, 2020, 4:30pm EDT
Register here.
This year’s US ECM Roundtable will be held as a virtual, two-part event, which will bring together senior market professionals to assess current themes in the industry and provide an outlook for the future.
The first webcast, titled The Great Equity Recapitalization in a Post-COVID-19
Monday, September 21, 2020 and Tuesday, September 22, 2020
Register here.
The PLI Pocket MBA is for attorneys representing clients in the financial industry. This two-day program is designed to improve your understanding of business strategies, accounting fundamentals and vocabulary used by management, investors, auditors and bankers.
Partner Jen Carlson, co-chair of the event,
On August 26, 2020, the U.S. Securities and Exchange Commission (“SEC”) adopted amendments to the definition of “accredited investor” and related amendments to the definition of “qualified institutional buyer.” The accredited investor definition is central to the regulation of exempt offerings. Consistent with the initial proposal, the amendments broaden the categories of individuals and entities
Special purpose acquisition companies (“SPACs”) are public shell companies that use their initial public offering (“IPO”) proceeds in order to acquire private companies within a specific timeframe. Although SPACs have existed for decades, merging into a SPAC has recently become an attractive alternative for private companies in lieu of undertaking traditional IPOs. Today, SPACs have
PIPE transactions continue to be a popular capital raising approach for companies. Through July 31, 2020, companies have raised over $47.2 billion in 779 PIPE transactions. Healthcare and life sciences companies raised almost $11 billion in PIPE transactions. Technology and industrials companies also raised significant amounts of capital, totaling $10.1 billion and $9.2 billion, respectively.
PIPE transactions were created to be an effective capital raising approach for public companies when there were few, if any, other satisfactory financing alternatives. While there are now a number of other confidentially marketed securities offering methodologies, for the reasons discussed in this article, PIPE transactions may be the most efficient or only alternative for
The private investment in public equity (PIPE) transaction has proven to be a popular financing tool in volatile markets. For the first five months of 2020, $29.3 billion has been raised through PIPE transactions, primarily in the healthcare and technology sectors.
Data source: PrivateRaise
Comparing timeframes (January 1 through June 9) year-over-year since 2015, there
June 17, 2020
9:00 AM – 10:00 AM EDT
Register here.
The US capital markets remain an attractive source of capital for emerging companies in the life sciences sector. A significant percentage of the 2019 U.S. initial public offerings were undertaken by life sciences companies. Despite the market uncertainty and volatility brought about by
During periods of market volatility, PIPE (private investment in public equity) transactions become an important financing alternative. During the financial crisis, financial institutions and other companies relied on PIPE transactions to raise significant capital. For example, in 2007, approximately $65.7 billion was raised in PIPE transactions, while in 2008, approximately $120.9 billion was raised. The